| Pfizer AG - Ibrance 75 mg, Filmtabletten | | 69183 | | 01 | | Ibrance 75 mg | | Filmtabletten | | L01EF01 | | Palbociclib | | 06.09.2023 | | |
| | Composition | | palbociclibum 75 mg, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, acidum succinicum, hypromellosum, E 171, triacetinum, E 132, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Palbociclibum | 75 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Palbociclibum | 75 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Rubrum) | | | | Acide Succinique | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 21 | 1973.56 | 2162.80 | A | LS | Non |
|
|
